More TrivarX Limited news
TrivarX LimitedASX: TRI

Medibio Submits FDA De Novo Application

Jul 15, 2018 at 11:42 PM EDT · Issued by TrivarX Limited

Filed with ASX · Jul 15, 2018 at 11:42 PM EDT

On 6ix: 6ix.com/news/medibio-submits-fda-de-novo-application

Trivarx Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

TrivarX Limited on 6ix

Earlier from TrivarX

  • Medibio Receives TGA ApprovalJun 19, 2018
  • MEB Signs Global Contract with Jacobs EngineeringMay 25, 2018
  • Medibio Announces Next Tranche of Corporate Health ContractsMay 9, 2018
  • Medibio Signs First Corporate Health ContractMay 8, 2018
  • Medibio Receives CE CertificationMay 2, 2018

Later from TrivarX

  • Departure of Managing Director & Chief Executive OfficerAug 28, 2018
  • Preliminary Final ReportAug 29, 2018
  • Clinical Study Shows Improvement to Diagnostic StandardSep 5, 2018
  • Executive Leadership ChangesSep 20, 2018
  • Notice Received Under Section 249D of the Corporations ActOct 1, 2018
All TrivarX news releases↗

Follow TrivarX into a list and get an email when it puts out news.

Follow TrivarX
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer